LAMEA Gastric Cancer Market Size, Share & Industry Trends Analysis Report By Route of Administration (Injectable and Oral), By Treatment Type, By Disease Type, By Distribution Channel, By Drug Class, By Country and Growth Forecast, 2023 - 2029

The Latin America, Middle East and Africa Gastric Cancer Market would witness market growth of 20.9% CAGR during the forecast period (2023-2029).

A promising potential in the market for treating gastric cancer is the development of combination treatments. Combined medicines can have several benefits, including increased efficacy and decreased toxicity compared to single-agent therapy. For patients with advanced gastric cancer, certain clinical trials have demonstrated that combining chemotherapy and immunotherapy can improve results.

It is also anticipated that other combination medicines, like targeted therapies and radiation therapy, may effectively treat gastric cancer. This strategy may assist in lessening adverse effects while improving treatment results. Due to the large unmet medical need for treating gastric cancer and the potential advantages of combination therapy, there is a considerable opportunity for businesses to create novel treatments in this field.

Cancer impacts over one million Latin Americans. The rising prevalence of cancer may be attributed to factors such as an aging demographic, the adoption of Westernized lifestyles, and urbanization. Los Angeles exhibits a high prevalence of gastric cancer compared to other nations. Gastric cancer is a significant health concern in Latin America, with several countries experiencing high mortality rates, including Chile, Costa Rica, and Colombia. The all-cause mortality rate is expected to increase in Latin America due to the developing and aging populations, resulting in a rise from fourteenth to eighth place shortly. The ASMR for males per 100,000 is higher in Honduras (22.3), Costa Rica (16.8), Peru (18.2), Chile (15.0), and Ecuador (20.7) compared to other regions of Latin America, such as Argentina.

The Brazil market dominated the LAMEA Gastric Cancer Market by Country in 2022, and would continue to be a dominant market till 2029; thereby, achieving a market value of $121.6 million by 2029. The Argentina market is estimated to grow a CAGR of 21.6% during (2023 - 2029). Additionally, The UAE market would showcase a CAGR of 20.6% during (2023 - 2029).

Based on Route of Administration, the market is segmented into Injectable and Oral. Based on Treatment Type, the market is segmented into Chemotherapy, Targeted Therapy, Immunotherapy, and Radiation Therapy & Surgery. Based on Disease Type, the market is segmented into Adenocarcinoma, Carcinoid Tumor, Gastrointestinal Stromal Tumor, Lymphoma and Others. Based on Distribution Channel, the market is segmented into Specialty & Retail Pharmacies, Hospital Pharmacies, and Others. Based on Drug Class, the market is segmented into PD-1/PD-L1 Inhibitors, HER2 Antagonists, VEGFR2 Antagonists and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

Free Valuable Insights: The Worldwide Gastric Cancer Market is Projected to reach USD 6.9 Billion by 2029, at a CAGR of 17.6%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Novartis AG, Pfizer, Inc., Viatris, Inc. (Mylan N.V.), F. Hoffmann-La Roche Ltd., Eli Lilly And Company, Merck & Co., Inc., Teva Pharmaceuticals Industries Ltd., Bristol Myers Squibb Company, Celltrion Healthcare Co., Ltd., and Samsung Biologics Co., Ltd. (Samsung Bioepis Co., Ltd.).

Scope of the Study

Market Segments Covered in the Report:

By Route of Administration

• Injectable
• Oral

By Treatment Type

• Chemotherapy
• Targeted Therapy
• Immunotherapy
• Radiation Therapy & Surgery

By Disease Type

• Adenocarcinoma
• Carcinoid Tumor
• Gastrointestinal Stromal Tumor
• Lymphoma
• Others

By Distribution Channel

• Specialty & Retail Pharmacies
• Hospital Pharmacies
• Others

By Drug Class

• PD-1/PD-L1 Inhibitors
• HER2 Antagonists
• VEGFR2 Antagonists
• Others

By Country

• Brazil
• Argentina
• UAE
• Saudi Arabia
• South Africa
• Nigeria
• Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

• Novartis AG
• Pfizer, Inc.
• Viatris, Inc. (Mylan N.V.)
• F. Hoffmann-La Roche Ltd.
• Eli Lilly And Company
• Merck & Co., Inc.
• Teva Pharmaceuticals Industries Ltd.
• Bristol Myers Squibb Company
• Celltrion Healthcare Co., Ltd.
• Samsung Biologics Co., Ltd. (Samsung Bioepis Co., Ltd.)

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Gastric Cancer Market, by Route of Administration
1.4.2 LAMEA Gastric Cancer Market, by Treatment Type
1.4.3 LAMEA Gastric Cancer Market, by Disease Type
1.4.4 LAMEA Gastric Cancer Market, by Distribution Channel
1.4.5 LAMEA Gastric Cancer Market, by Drug Class
1.4.6 LAMEA Gastric Cancer Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Approvals & Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)

Chapter 4. LAMEA Gastric Cancer Market by Route of Administration
4.1 LAMEA Injectable Market by Country
4.2 LAMEA Oral Market by Country

Chapter 5. LAMEA Gastric Cancer Market by Treatment Type
5.1 LAMEA Chemotherapy Market by Country
5.2 LAMEA Targeted Therapy Market by Country
5.3 LAMEA Immunotherapy Market by Country
5.4 LAMEA Radiation Therapy & Surgery Market by Country

Chapter 6. LAMEA Gastric Cancer Market by Disease Type
6.1 LAMEA Adenocarcinoma Market by Country
6.2 LAMEA Carcinoid Tumor Market by Country
6.3 LAMEA Gastrointestinal Stromal Tumor Market by Country
6.4 LAMEA Lymphoma Market by Country
6.5 LAMEA Others Market by Country

Chapter 7. LAMEA Gastric Cancer Market by Distribution Channel
7.1 LAMEA Specialty & Retail Pharmacies Market by Country
7.2 LAMEA Hospital Pharmacies Market by Country
7.3 LAMEA Others Market by Country

Chapter 8. LAMEA Gastric Cancer Market by Drug Class
8.1 LAMEA PD-1/PD-L1 Inhibitors Market by Country
8.2 LAMEA HER2 Antagonists Market by Country
8.3 LAMEA VEGFR2 Antagonists Market by Country
8.4 LAMEA Others Market by Country

Chapter 9. LAMEA Gastric Cancer Market by Country
9.1 Brazil Gastric Cancer Market
9.1.1 Brazil Gastric Cancer Market by Route of Administration
9.1.2 Brazil Gastric Cancer Market by Treatment Type
9.1.3 Brazil Gastric Cancer Market by Disease Type
9.1.4 Brazil Gastric Cancer Market by Distribution Channel
9.1.5 Brazil Gastric Cancer Market by Drug Class
9.2 Argentina Gastric Cancer Market
9.2.1 Argentina Gastric Cancer Market by Route of Administration
9.2.2 Argentina Gastric Cancer Market by Treatment Type
9.2.3 Argentina Gastric Cancer Market by Disease Type
9.2.4 Argentina Gastric Cancer Market by Distribution Channel
9.2.5 Argentina Gastric Cancer Market by Drug Class
9.3 UAE Gastric Cancer Market
9.3.1 UAE Gastric Cancer Market by Route of Administration
9.3.2 UAE Gastric Cancer Market by Treatment Type
9.3.3 UAE Gastric Cancer Market by Disease Type
9.3.4 UAE Gastric Cancer Market by Distribution Channel
9.3.5 UAE Gastric Cancer Market by Drug Class
9.4 Saudi Arabia Gastric Cancer Market
9.4.1 Saudi Arabia Gastric Cancer Market by Route of Administration
9.4.2 Saudi Arabia Gastric Cancer Market by Treatment Type
9.4.3 Saudi Arabia Gastric Cancer Market by Disease Type
9.4.4 Saudi Arabia Gastric Cancer Market by Distribution Channel
9.4.5 Saudi Arabia Gastric Cancer Market by Drug Class
9.5 South Africa Gastric Cancer Market
9.5.1 South Africa Gastric Cancer Market by Route of Administration
9.5.2 South Africa Gastric Cancer Market by Treatment Type
9.5.3 South Africa Gastric Cancer Market by Disease Type
9.5.4 South Africa Gastric Cancer Market by Distribution Channel
9.5.5 South Africa Gastric Cancer Market by Drug Class
9.6 Nigeria Gastric Cancer Market
9.6.1 Nigeria Gastric Cancer Market by Route of Administration
9.6.2 Nigeria Gastric Cancer Market by Treatment Type
9.6.3 Nigeria Gastric Cancer Market by Disease Type
9.6.4 Nigeria Gastric Cancer Market by Distribution Channel
9.6.5 Nigeria Gastric Cancer Market by Drug Class
9.7 Rest of LAMEA Gastric Cancer Market
9.7.1 Rest of LAMEA Gastric Cancer Market by Route of Administration
9.7.2 Rest of LAMEA Gastric Cancer Market by Treatment Type
9.7.3 Rest of LAMEA Gastric Cancer Market by Disease Type
9.7.4 Rest of LAMEA Gastric Cancer Market by Distribution Channel
9.7.5 Rest of LAMEA Gastric Cancer Market by Drug Class

Chapter 10. Company Profiles
10.1 Novartis AG
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Segmental and Regional Analysis
10.1.4 Research & Development Expense
10.1.5 Recent strategies and developments:
10.1.5.1 Partnerships, Collaborations, and Agreements:
10.2 Pfizer, Inc.
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Regional & Segmental Analysis
10.2.4 Research & Development Expense
10.2.5 Recent strategies and developments:
10.2.5.1 Partnerships, Collaborations, and Agreements:
10.3 Viatris, Inc. (Mylan N.V.)
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Segmental Analysis
10.3.4 Research & Development Expense
10.3.5 Recent strategies and developments:
10.3.5.1 Product Launches and Product Expansions:
10.3.5.2 Approvals & Trials:
10.4 F. Hoffmann-La Roche Ltd.
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Segmental and Regional Analysis
10.4.4 Research & Development Expense
10.4.5 Recent strategies and developments:
10.4.5.1 Partnerships, Collaborations, and Agreements:
10.4.5.2 Product Launches and Product Expansions:
10.5 Eli Lilly And Company
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Regional Analysis
10.5.4 Research & Development Expenses
10.5.5 Recent strategies and developments:
10.5.5.1 Approvals & Trials:
10.5.5.2 Partnerships, Collaborations, and Agreements:
10.6 Merck & Co., Inc.
10.6.1 Company Overview
10.6.2 Financial Analysis
10.6.3 Segmental and Regional Analysis
10.6.4 Research & Development Expenses
10.6.5 Recent strategies and developments:
10.6.5.1 Partnerships, Collaborations, and Agreements:
10.7 Teva Pharmaceutical Industries Ltd.
10.7.1 Company Overview
10.7.2 Financial Analysis
10.7.3 Regional Analysis
10.7.4 Research & Development Expenses
10.7.5 Recent strategies and developments:
10.7.5.1 Product Launches and Product Expansions:
10.7.5.2 Approvals & Trials:
10.7.5.3 Partnerships, Collaborations, and Agreements:
10.8 Bristol Myers Squibb Company
10.8.1 Company Overview
10.8.2 Financial Analysis
10.8.3 Regional Analysis
10.8.4 Research & Development Expenses
10.8.5 Recent strategies and developments:
10.8.5.1 Partnerships, Collaborations, and Agreements:
10.8.5.2 Approvals & Trials:
10.9 Celltrion Healthcare Co., Ltd.
10.9.1 Company Overview
10.9.2 Financial Analysis
10.9.3 Recent strategies and developments:
10.9.3.1 Partnerships, Collaborations, and Agreements:
10.10. Samsung Biologics Co., Ltd. (Samsung Bioepis Co., Ltd.)
10.10.1 Company Overview
10.10.2 Financial Analysis
10.10.3 Segmental and Regional Analysis
10.10.4 Research & Development Expenses
10.10.5 Recent strategies and developments:
10.10.5.1 Approvals & Trials:
10.10.5.2 Product Launches and Product Expansions:

TABLE 1 LAMEA Gastric Cancer Market, 2019 - 2022, USD Million
TABLE 2 LAMEA Gastric Cancer Market, 2023 - 2029, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Gastric Cancer Market
TABLE 4 Product Launches And Product Expansions– Gastric Cancer Market
TABLE 5 Approvals & Trials – Gastric Cancer Market
TABLE 6 LAMEA Gastric Cancer Market by Route of Administration, 2019 - 2022, USD Million
TABLE 7 LAMEA Gastric Cancer Market by Route of Administration, 2023 - 2029, USD Million
TABLE 8 LAMEA Injectable Market by Country, 2019 - 2022, USD Million
TABLE 9 LAMEA Injectable Market by Country, 2023 - 2029, USD Million
TABLE 10 LAMEA Oral Market by Country, 2019 - 2022, USD Million
TABLE 11 LAMEA Oral Market by Country, 2023 - 2029, USD Million
TABLE 12 LAMEA Gastric Cancer Market by Treatment Type, 2019 - 2022, USD Million
TABLE 13 LAMEA Gastric Cancer Market by Treatment Type, 2023 - 2029, USD Million
TABLE 14 LAMEA Chemotherapy Market by Country, 2019 - 2022, USD Million
TABLE 15 LAMEA Chemotherapy Market by Country, 2023 - 2029, USD Million
TABLE 16 LAMEA Targeted Therapy Market by Country, 2019 - 2022, USD Million
TABLE 17 LAMEA Targeted Therapy Market by Country, 2023 - 2029, USD Million
TABLE 18 LAMEA Immunotherapy Market by Country, 2019 - 2022, USD Million
TABLE 19 LAMEA Immunotherapy Market by Country, 2023 - 2029, USD Million
TABLE 20 LAMEA Radiation Therapy & Surgery Market by Country, 2019 - 2022, USD Million
TABLE 21 LAMEA Radiation Therapy & Surgery Market by Country, 2023 - 2029, USD Million
TABLE 22 LAMEA Gastric Cancer Market by Disease Type, 2019 - 2022, USD Million
TABLE 23 LAMEA Gastric Cancer Market by Disease Type, 2023 - 2029, USD Million
TABLE 24 LAMEA Adenocarcinoma Market by Country, 2019 - 2022, USD Million
TABLE 25 LAMEA Adenocarcinoma Market by Country, 2023 - 2029, USD Million
TABLE 26 LAMEA Carcinoid Tumor Market by Country, 2019 - 2022, USD Million
TABLE 27 LAMEA Carcinoid Tumor Market by Country, 2023 - 2029, USD Million
TABLE 28 LAMEA Gastrointestinal Stromal Tumor Market by Country, 2019 - 2022, USD Million
TABLE 29 LAMEA Gastrointestinal Stromal Tumor Market by Country, 2023 - 2029, USD Million
TABLE 30 LAMEA Lymphoma Market by Country, 2019 - 2022, USD Million
TABLE 31 LAMEA Lymphoma Market by Country, 2023 - 2029, USD Million
TABLE 32 LAMEA Others Market by Country, 2019 - 2022, USD Million
TABLE 33 LAMEA Others Market by Country, 2023 - 2029, USD Million
TABLE 34 LAMEA Gastric Cancer Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 35 LAMEA Gastric Cancer Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 36 LAMEA Specialty & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 37 LAMEA Specialty & Retail Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 38 LAMEA Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 39 LAMEA Hospital Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 40 LAMEA Others Market by Country, 2019 - 2022, USD Million
TABLE 41 LAMEA Others Market by Country, 2023 - 2029, USD Million
TABLE 42 LAMEA Gastric Cancer Market by Drug Class, 2019 - 2022, USD Million
TABLE 43 LAMEA Gastric Cancer Market by Drug Class, 2023 - 2029, USD Million
TABLE 44 LAMEA PD-1/PD-L1 Inhibitors Market by Country, 2019 - 2022, USD Million
TABLE 45 LAMEA PD-1/PD-L1 Inhibitors Market by Country, 2023 - 2029, USD Million
TABLE 46 LAMEA HER2 Antagonists Market by Country, 2019 - 2022, USD Million
TABLE 47 LAMEA HER2 Antagonists Market by Country, 2023 - 2029, USD Million
TABLE 48 LAMEA VEGFR2 Antagonists Market by Country, 2019 - 2022, USD Million
TABLE 49 LAMEA VEGFR2 Antagonists Market by Country, 2023 - 2029, USD Million
TABLE 50 LAMEA Others Market by Country, 2019 - 2022, USD Million
TABLE 51 LAMEA Others Market by Country, 2023 - 2029, USD Million
TABLE 52 LAMEA Gastric Cancer Market by Country, 2019 - 2022, USD Million
TABLE 53 LAMEA Gastric Cancer Market by Country, 2023 - 2029, USD Million
TABLE 54 Brazil Gastric Cancer Market, 2019 - 2022, USD Million
TABLE 55 Brazil Gastric Cancer Market, 2023 - 2029, USD Million
TABLE 56 Brazil Gastric Cancer Market by Route of Administration, 2019 - 2022, USD Million
TABLE 57 Brazil Gastric Cancer Market by Route of Administration, 2023 - 2029, USD Million
TABLE 58 Brazil Gastric Cancer Market by Treatment Type, 2019 - 2022, USD Million
TABLE 59 Brazil Gastric Cancer Market by Treatment Type, 2023 - 2029, USD Million
TABLE 60 Brazil Gastric Cancer Market by Disease Type, 2019 - 2022, USD Million
TABLE 61 Brazil Gastric Cancer Market by Disease Type, 2023 - 2029, USD Million
TABLE 62 Brazil Gastric Cancer Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 63 Brazil Gastric Cancer Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 64 Brazil Gastric Cancer Market by Drug Class, 2019 - 2022, USD Million
TABLE 65 Brazil Gastric Cancer Market by Drug Class, 2023 - 2029, USD Million
TABLE 66 Argentina Gastric Cancer Market, 2019 - 2022, USD Million
TABLE 67 Argentina Gastric Cancer Market, 2023 - 2029, USD Million
TABLE 68 Argentina Gastric Cancer Market by Route of Administration, 2019 - 2022, USD Million
TABLE 69 Argentina Gastric Cancer Market by Route of Administration, 2023 - 2029, USD Million
TABLE 70 Argentina Gastric Cancer Market by Treatment Type, 2019 - 2022, USD Million
TABLE 71 Argentina Gastric Cancer Market by Treatment Type, 2023 - 2029, USD Million
TABLE 72 Argentina Gastric Cancer Market by Disease Type, 2019 - 2022, USD Million
TABLE 73 Argentina Gastric Cancer Market by Disease Type, 2023 - 2029, USD Million
TABLE 74 Argentina Gastric Cancer Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 75 Argentina Gastric Cancer Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 76 Argentina Gastric Cancer Market by Drug Class, 2019 - 2022, USD Million
TABLE 77 Argentina Gastric Cancer Market by Drug Class, 2023 - 2029, USD Million
TABLE 78 UAE Gastric Cancer Market, 2019 - 2022, USD Million
TABLE 79 UAE Gastric Cancer Market, 2023 - 2029, USD Million
TABLE 80 UAE Gastric Cancer Market by Route of Administration, 2019 - 2022, USD Million
TABLE 81 UAE Gastric Cancer Market by Route of Administration, 2023 - 2029, USD Million
TABLE 82 UAE Gastric Cancer Market by Treatment Type, 2019 - 2022, USD Million
TABLE 83 UAE Gastric Cancer Market by Treatment Type, 2023 - 2029, USD Million
TABLE 84 UAE Gastric Cancer Market by Disease Type, 2019 - 2022, USD Million
TABLE 85 UAE Gastric Cancer Market by Disease Type, 2023 - 2029, USD Million
TABLE 86 UAE Gastric Cancer Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 87 UAE Gastric Cancer Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 88 UAE Gastric Cancer Market by Drug Class, 2019 - 2022, USD Million
TABLE 89 UAE Gastric Cancer Market by Drug Class, 2023 - 2029, USD Million
TABLE 90 Saudi Arabia Gastric Cancer Market, 2019 - 2022, USD Million
TABLE 91 Saudi Arabia Gastric Cancer Market, 2023 - 2029, USD Million
TABLE 92 Saudi Arabia Gastric Cancer Market by Route of Administration, 2019 - 2022, USD Million
TABLE 93 Saudi Arabia Gastric Cancer Market by Route of Administration, 2023 - 2029, USD Million
TABLE 94 Saudi Arabia Gastric Cancer Market by Treatment Type, 2019 - 2022, USD Million
TABLE 95 Saudi Arabia Gastric Cancer Market by Treatment Type, 2023 - 2029, USD Million
TABLE 96 Saudi Arabia Gastric Cancer Market by Disease Type, 2019 - 2022, USD Million
TABLE 97 Saudi Arabia Gastric Cancer Market by Disease Type, 2023 - 2029, USD Million
TABLE 98 Saudi Arabia Gastric Cancer Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 99 Saudi Arabia Gastric Cancer Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 100 Saudi Arabia Gastric Cancer Market by Drug Class, 2019 - 2022, USD Million
TABLE 101 Saudi Arabia Gastric Cancer Market by Drug Class, 2023 - 2029, USD Million
TABLE 102 South Africa Gastric Cancer Market, 2019 - 2022, USD Million
TABLE 103 South Africa Gastric Cancer Market, 2023 - 2029, USD Million
TABLE 104 South Africa Gastric Cancer Market by Route of Administration, 2019 - 2022, USD Million
TABLE 105 South Africa Gastric Cancer Market by Route of Administration, 2023 - 2029, USD Million
TABLE 106 South Africa Gastric Cancer Market by Treatment Type, 2019 - 2022, USD Million
TABLE 107 South Africa Gastric Cancer Market by Treatment Type, 2023 - 2029, USD Million
TABLE 108 South Africa Gastric Cancer Market by Disease Type, 2019 - 2022, USD Million
TABLE 109 South Africa Gastric Cancer Market by Disease Type, 2023 - 2029, USD Million
TABLE 110 South Africa Gastric Cancer Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 111 South Africa Gastric Cancer Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 112 South Africa Gastric Cancer Market by Drug Class, 2019 - 2022, USD Million
TABLE 113 South Africa Gastric Cancer Market by Drug Class, 2023 - 2029, USD Million
TABLE 114 Nigeria Gastric Cancer Market, 2019 - 2022, USD Million
TABLE 115 Nigeria Gastric Cancer Market, 2023 - 2029, USD Million
TABLE 116 Nigeria Gastric Cancer Market by Route of Administration, 2019 - 2022, USD Million
TABLE 117 Nigeria Gastric Cancer Market by Route of Administration, 2023 - 2029, USD Million
TABLE 118 Nigeria Gastric Cancer Market by Treatment Type, 2019 - 2022, USD Million
TABLE 119 Nigeria Gastric Cancer Market by Treatment Type, 2023 - 2029, USD Million
TABLE 120 Nigeria Gastric Cancer Market by Disease Type, 2019 - 2022, USD Million
TABLE 121 Nigeria Gastric Cancer Market by Disease Type, 2023 - 2029, USD Million
TABLE 122 Nigeria Gastric Cancer Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 123 Nigeria Gastric Cancer Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 124 Nigeria Gastric Cancer Market by Drug Class, 2019 - 2022, USD Million
TABLE 125 Nigeria Gastric Cancer Market by Drug Class, 2023 - 2029, USD Million
TABLE 126 Rest of LAMEA Gastric Cancer Market, 2019 - 2022, USD Million
TABLE 127 Rest of LAMEA Gastric Cancer Market, 2023 - 2029, USD Million
TABLE 128 Rest of LAMEA Gastric Cancer Market by Route of Administration, 2019 - 2022, USD Million
TABLE 129 Rest of LAMEA Gastric Cancer Market by Route of Administration, 2023 - 2029, USD Million
TABLE 130 Rest of LAMEA Gastric Cancer Market by Treatment Type, 2019 - 2022, USD Million
TABLE 131 Rest of LAMEA Gastric Cancer Market by Treatment Type, 2023 - 2029, USD Million
TABLE 132 Rest of LAMEA Gastric Cancer Market by Disease Type, 2019 - 2022, USD Million
TABLE 133 Rest of LAMEA Gastric Cancer Market by Disease Type, 2023 - 2029, USD Million
TABLE 134 Rest of LAMEA Gastric Cancer Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 135 Rest of LAMEA Gastric Cancer Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 136 Rest of LAMEA Gastric Cancer Market by Drug Class, 2019 - 2022, USD Million
TABLE 137 Rest of LAMEA Gastric Cancer Market by Drug Class, 2023 - 2029, USD Million
TABLE 138 Key Information – Novartis AG
TABLE 139 Key Information – Pfizer, Inc.
TABLE 140 key information – Viatris, Inc.
TABLE 141 KEY INFORMATION – F. Hoffmann-La Roche Ltd.
TABLE 142 Key Information – Eli Lilly And Company
TABLE 143 KEY INFORMATION - Merck & Co., Inc.
TABLE 144 Key Information – Teva Pharmaceuticals Industries Ltd.
TABLE 145 Key Information – Bristol Myers Squibb Company
TABLE 146 Key Information – Celltrion Healthcare Co., Ltd.
TABLE 147 Key Information – Samsung Biologics Co., Ltd.

List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2019-2023)
FIG 4 Recent strategies and developments: Viatris, Inc.
FIG 5 Recent strategies and developments: F. Hoffmann-La Roche Ltd.
FIG 6 Recent strategies and developments: Teva Pharmaceuticals Industries Ltd.
FIG 7 Recent strategies and developments: Samsung Biologics Co., Ltd.